suven life sciences' pashamylaram facility successfully completes usfda inspection
.
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".
written reports, including local media accounts, professional medical papers and internal emails were also examined..experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy (file pic).